proxyvotesnow.com

Home › Companies › NEOGENOMICS INC. › 2023-2024

NEOGENOMICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and NEOGENOMICS INC.’s Form 8-K, filed 2024-05-24 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 12Ballot items
  • 312Asset managers
  • 3,787Fund votes
  • 2024-05-23Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore NEOGENOMICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by NEOGENOMICS INC.

These tallies are NEOGENOMICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-05-24 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

NEOGENOMICS INC. — official shareholder meeting results, meeting held 2024-05-23
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Lynn A. Tetrault 83,003,873---- 27,070,6607,524,229 Majority: yes
Elect Director: Christopher M. Smith 109,124,682---- 949,8517,524,229 Majority: yes
Elect Director: Dr. Alison L. Hannah 107,190,288---- 2,884,2457,524,229 Majority: yes
Elect Director: Stephen M. Kanovsky 107,073,992---- 3,000,5417,524,229 Majority: yes
Elect Director: Michael A. Kelly 84,662,179---- 25,412,3547,524,229 Majority: yes
Elect Director: David B. Perez 109,230,796---- 843,7377,524,229 Majority: yes
Elect Director: Anthony P. Zook 108,543,639---- 1,530,8947,524,229 Majority: yes
Elect Director: Elizabeth Floegel 109,748,045---- 326,4887,524,229 Majority: yes
Elect Director: Dr. Neil Gunn 108,284,625---- 1,789,9087,524,229 Majority: yes
Proposal 2: The approval, on an advisory basis, of the compensation paid to the Company's Named Executive Officers, as identified in the proxy statement for the annual meeting. The advisory approval received an affirmative vote of a majority of the votes cast 76,045,75333,308,929719,851 ---- Majority: yes
Proposal 3: The approval of the Fourth Amendment of the Employee Stock Purchase Plan, as amended and restated, as identified in the proxy statement for the annual meeting. The stockholders approved the proposal by the following vote: 109,699,121246,194129,218 ---- Majority: yes
Proposal 4: The ratification of the appointment of Deloitte & Touche LLP as the independent registered public accountant. The stockholders approved the proposal by the following vote: 117,159,931384,03454,797 ---- Majority: yes

Source: NEOGENOMICS INC., Form 8-K, filed with the SEC on 2024-05-24 — read the filing on EDGAR.

How asset managers voted at the NEOGENOMICS INC. 2023-2024 meeting

Each item below shows how the 312 asset managers that disclosed a NEOGENOMICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Approval, on an advisory basis, of the Compensation Paid to the Company's Named Executive Officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 11 wordings of this item as funds reported it.

70% Majority: yes · of votes cast

FOR 70%AGAINST 30%
FOR: 76,045,753AGAINST: 33,308,929

NEOGENOMICS INC.’s own tally for this item (“Proposal 2: The approval, on an advisory basis, of the compensation paid to the Company's Named Executive Officers, as identified in the proxy statement for the annual meeting. The advisory approval received an affirmati”): 76,045,753 for, 33,308,929 against, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,434,786 outstanding shares: 60% for, 26% against (86% of the company cast a for/against vote).

The 309 asset managers below cast 62% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 62%AGAINST 38%
FOR: 61.7%AGAINST: 37.8%ABSTAIN: 0.4%NOT VOTED: 0.1%
Largest asset managers voting on “Approval, on an advisory basis, of the Compensation Paid to the Company's Named Executive Officers.” at NEOGENOMICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
New York Life290,29817,000,000 00Against
BlackRock15,398,98345,658 00For
Vanguard14,199,9900 00For
T. Rowe Price11,537,9781,089,054 00For
BROWN ADVISORY INC8,175,68123,686 00For
State Street6,265,44447,778 00For
Janus Henderson3,907,6151,760,670 00For
JANUS INVESTMENT FUND3,693,982926,819 00For
American Century04,596,839 00Against
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST03,765,090 00Against
SCHRODER INVESTMENT MANAGEMENT GROUP03,485,106 00Against
First Light Asset Management, LLC3,241,4740 00For
Brown Advisory Funds3,130,9870 00For
Greenhouse Funds LLLP3,038,2780 00For
GEODE CAPITAL MANAGEMENT, LLC2,863,3330 00For
Fidelity2,787,8290 00For
Goldman Sachs551,7671,970,123 00Against
Delaware/Macquarie02,495,020 00Against
Charles Schwab2,205,7160 00For
Principal1,560,229145,548 00For
WEATHERBIE CAPITAL, LLC01,572,727 00Against
EMERALD MUTUAL FUND ADVISERS TRUST1,557,8950 00For
Northern Trust1,483,26418,059 00For
Putnam1,367,9840 00For
FRANKLIN ADVISERS INC1,285,45057,264 00For

Showing the 25 largest of 309 asset managers. See all 309 in the interactive database.

2. Approval of the Fourth Amendment of the NeoGenomics, Inc. Employee Stock Purchase Plan (as amended and restated).

COMPENSATIONMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 109,699,121AGAINST: 246,194

NEOGENOMICS INC.’s own tally for this item (“Proposal 3: The approval of the Fourth Amendment of the Employee Stock Purchase Plan, as amended and restated, as identified in the proxy statement for the annual meeting. The stockholders approved the proposal by the fo”): 109,699,121 for, 246,194 against, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,434,786 outstanding shares: 86% for, 0.2% against (86% of the company cast a for/against vote).

The 93 asset managers below cast 99.9% of the shares they voted on this item FOR (69,234,730 for, 10,157 against).

FOR 99.8%
FOR: 69,234,730 (99.8%)AGAINST: 10,157 (0.0%)NOT VOTED: 98,642 (0.1%)
Largest asset managers voting on “Approval of the Fourth Amendment of the NeoGenomics, Inc. Employee Stock Purchase Plan (as amended and restate” at NEOGENOMICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,967,2100 00For
BlackRock12,124,7710 00For
T. Rowe Price5,198,1840 00For
JANUS INVESTMENT FUND4,620,8010 00For
First Light Asset Management, LLC3,241,4740 00For
Brown Advisory Funds3,130,9870 00For
Fidelity2,778,1350 00For
Delaware/Macquarie2,495,0200 00For
American Century2,181,0420 00For
State Street1,893,6910 00For
Principal1,705,7770 00For
Goldman Sachs1,348,9700 00For
FRANKLIN STRATEGIC SERIES1,270,4000 00For
GLENMEDE FUND INC1,057,0490 00For
Charles Schwab1,011,5570 00For
FINANCIAL INVESTORS TRUST817,4380 00For
OBERWEIS FUNDS732,2000 00For
Waddell & Reed710,7690 00For
Putnam667,0820 00For
ALGER FUNDS643,9420 00For
Prudential/PGIM550,6500 00For
Columbia Threadneedle516,6690 00For
TIAA512,4210 00For
Royce398,0770 00For
Segall Bryant & Hamill Trust379,3580 00For

Showing the 25 largest of 93 asset managers. See all 93 in the interactive database.

3. Election of the directors named in the proxy statement as set forth below: Anthony P. Zook

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 108,543,639WITHHELD: 1,530,894

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Anthony P. Zook”): 108,543,639 for, 1,530,894 withheld, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,434,786 outstanding shares: 85% for, 1% withheld (86% of the company cast a for/withheld vote).

The 91 asset managers below cast 100% of the shares they voted on this item FOR (65,355,893 for, 0 against).

FOR 99%
FOR: 65,355,893 (98.9%)ABSTAIN: 646,629 (1.0%)NOT VOTED: 98,642 (0.1%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Anthony P. Zook” at NEOGENOMICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,967,2100 00For
BlackRock12,124,7710 00For
T. Rowe Price5,198,1840 00For
JANUS INVESTMENT FUND4,620,8010 00For
Brown Advisory Funds3,130,9870 00For
Fidelity2,778,1350 00For
Delaware/Macquarie2,495,0200 00For
American Century2,181,0420 00For
State Street1,893,6910 00For
Principal1,705,7770 00For
Goldman Sachs1,348,9700 00For
FRANKLIN STRATEGIC SERIES1,270,4000 00For
GLENMEDE FUND INC1,057,0490 00For
Charles Schwab1,011,5570 00For
FINANCIAL INVESTORS TRUST817,4380 00For
OBERWEIS FUNDS732,2000 00For
Waddell & Reed710,7690 00For
Putnam667,0820 00For
ALGER FUNDS643,9420 00For
Prudential/PGIM550,6500 00For
Columbia Threadneedle516,6690 00For
TIAA00 512,4210Abstain
Royce398,0770 00For
Segall Bryant & Hamill Trust379,3580 00For
Equitable356,7260 00For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

4. Election of the directors named in the proxy statement as set forth below: Christopher M. Smith

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 109,124,682WITHHELD: 949,851

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Christopher M. Smith”): 109,124,682 for, 949,851 withheld, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,434,786 outstanding shares: 86% for, 0.8% withheld (86% of the company cast a for/withheld vote).

The 91 asset managers below cast 100% of the shares they voted on this item FOR (65,991,927 for, 0 against).

FOR 99.8%
FOR: 65,991,927 (99.8%)ABSTAIN: 10,595 (0.0%)NOT VOTED: 98,642 (0.1%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Christopher M. Smith” at NEOGENOMICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,967,2100 00For
BlackRock12,124,7710 00For
T. Rowe Price5,198,1840 00For
JANUS INVESTMENT FUND4,620,8010 00For
Brown Advisory Funds3,130,9870 00For
Fidelity2,778,1350 00For
Delaware/Macquarie2,495,0200 00For
American Century2,181,0420 00For
State Street1,893,2530 4380For
Principal1,705,7770 00For
Goldman Sachs1,348,9700 00For
FRANKLIN STRATEGIC SERIES1,270,4000 00For
GLENMEDE FUND INC1,057,0490 00For
Charles Schwab1,011,5570 00For
FINANCIAL INVESTORS TRUST817,4380 00For
OBERWEIS FUNDS732,2000 00For
Waddell & Reed710,7690 00For
Putnam667,0820 00For
ALGER FUNDS643,9420 00For
Prudential/PGIM550,6500 00For
Columbia Threadneedle516,6690 00For
TIAA512,4210 00For
Royce398,0770 00For
Segall Bryant & Hamill Trust379,3580 00For
Equitable356,7260 00For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

5. Election of the directors named in the proxy statement as set forth below: David B. Perez

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 109,230,796WITHHELD: 843,737

NEOGENOMICS INC.’s own tally for this item (“Elect Director: David B. Perez”): 109,230,796 for, 843,737 withheld, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,434,786 outstanding shares: 86% for, 0.7% withheld (86% of the company cast a for/withheld vote).

The 91 asset managers below cast 100% of the shares they voted on this item FOR (65,991,927 for, 0 against).

FOR 99.8%
FOR: 65,991,927 (99.8%)ABSTAIN: 10,595 (0.0%)NOT VOTED: 98,642 (0.1%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: David B. Perez” at NEOGENOMICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,967,2100 00For
BlackRock12,124,7710 00For
T. Rowe Price5,198,1840 00For
JANUS INVESTMENT FUND4,620,8010 00For
Brown Advisory Funds3,130,9870 00For
Fidelity2,778,1350 00For
Delaware/Macquarie2,495,0200 00For
American Century2,181,0420 00For
State Street1,893,2530 4380For
Principal1,705,7770 00For
Goldman Sachs1,348,9700 00For
FRANKLIN STRATEGIC SERIES1,270,4000 00For
GLENMEDE FUND INC1,057,0490 00For
Charles Schwab1,011,5570 00For
FINANCIAL INVESTORS TRUST817,4380 00For
OBERWEIS FUNDS732,2000 00For
Waddell & Reed710,7690 00For
Putnam667,0820 00For
ALGER FUNDS643,9420 00For
Prudential/PGIM550,6500 00For
Columbia Threadneedle516,6690 00For
TIAA512,4210 00For
Royce398,0770 00For
Segall Bryant & Hamill Trust379,3580 00For
Equitable356,7260 00For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

6. Election of the directors named in the proxy statement as set forth below: Dr. Alison L. Hannah

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 107,190,288WITHHELD: 2,884,245

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Dr. Alison L. Hannah”): 107,190,288 for, 2,884,245 withheld, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,434,786 outstanding shares: 84% for, 2% withheld (86% of the company cast a for/withheld vote).

The 91 asset managers below cast 100% of the shares they voted on this item FOR (65,252,862 for, 0 against).

FOR 99%
FOR: 65,252,862 (98.7%)ABSTAIN: 749,660 (1.1%)NOT VOTED: 98,642 (0.1%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Dr. Alison L. Hannah” at NEOGENOMICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,967,2100 00For
BlackRock12,124,7710 00For
T. Rowe Price5,198,1840 00For
JANUS INVESTMENT FUND4,620,8010 00For
Brown Advisory Funds3,130,9870 00For
Fidelity2,778,1350 00For
Delaware/Macquarie2,495,0200 00For
American Century2,181,0420 00For
State Street1,892,9160 7750For
Principal1,705,7770 00For
Goldman Sachs1,348,9700 00For
FRANKLIN STRATEGIC SERIES1,270,4000 00For
GLENMEDE FUND INC1,057,0490 00For
Charles Schwab1,011,5570 00For
FINANCIAL INVESTORS TRUST817,4380 00For
OBERWEIS FUNDS732,2000 00For
Waddell & Reed710,7690 00For
Putnam667,0820 00For
ALGER FUNDS00 643,9420Abstain
Prudential/PGIM550,6500 00For
Columbia Threadneedle516,6690 00For
TIAA512,4210 00For
Royce398,0770 00For
Segall Bryant & Hamill Trust379,3580 00For
Equitable356,7260 00For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

7. Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 108,284,625WITHHELD: 1,789,908

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Dr. Neil Gunn”): 108,284,625 for, 1,789,908 withheld, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,434,786 outstanding shares: 85% for, 1% withheld (86% of the company cast a for/withheld vote).

The 91 asset managers below cast 100% of the shares they voted on this item FOR (65,377,702 for, 0 against).

FOR 99%
FOR: 65,377,702 (98.9%)ABSTAIN: 624,820 (0.9%)NOT VOTED: 98,642 (0.1%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Dr. Neil Gunn” at NEOGENOMICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,967,2100 00For
BlackRock12,124,7710 00For
T. Rowe Price5,198,1840 00For
JANUS INVESTMENT FUND4,620,8010 00For
Brown Advisory Funds3,130,9870 00For
Fidelity2,778,1350 00For
Delaware/Macquarie2,495,0200 00For
American Century2,181,0420 00For
State Street1,893,6910 00For
Principal1,705,7770 00For
Goldman Sachs1,348,9700 00For
FRANKLIN STRATEGIC SERIES1,270,4000 00For
GLENMEDE FUND INC1,057,0490 00For
Charles Schwab1,011,5570 00For
FINANCIAL INVESTORS TRUST817,4380 00For
OBERWEIS FUNDS732,2000 00For
Waddell & Reed710,7690 00For
Putnam667,0820 00For
ALGER FUNDS643,9420 00For
Prudential/PGIM550,6500 00For
Columbia Threadneedle516,6690 00For
TIAA00 512,4210Abstain
Royce398,0770 00For
Segall Bryant & Hamill Trust379,3580 00For
Equitable356,7260 00For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

8. Election of the directors named in the proxy statement as set forth below: Elizabeth Floegel

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 109,748,045WITHHELD: 326,488

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Elizabeth Floegel”): 109,748,045 for, 326,488 withheld, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,434,786 outstanding shares: 86% for, 0.3% withheld (86% of the company cast a for/withheld vote).

The 91 asset managers below cast 100% of the shares they voted on this item FOR (65,992,365 for, 0 against).

FOR 99.8%
FOR: 65,992,365 (99.8%)ABSTAIN: 10,157 (0.0%)NOT VOTED: 98,642 (0.1%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Elizabeth Floegel” at NEOGENOMICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,967,2100 00For
BlackRock12,124,7710 00For
T. Rowe Price5,198,1840 00For
JANUS INVESTMENT FUND4,620,8010 00For
Brown Advisory Funds3,130,9870 00For
Fidelity2,778,1350 00For
Delaware/Macquarie2,495,0200 00For
American Century2,181,0420 00For
State Street1,893,6910 00For
Principal1,705,7770 00For
Goldman Sachs1,348,9700 00For
FRANKLIN STRATEGIC SERIES1,270,4000 00For
GLENMEDE FUND INC1,057,0490 00For
Charles Schwab1,011,5570 00For
FINANCIAL INVESTORS TRUST817,4380 00For
OBERWEIS FUNDS732,2000 00For
Waddell & Reed710,7690 00For
Putnam667,0820 00For
ALGER FUNDS643,9420 00For
Prudential/PGIM550,6500 00For
Columbia Threadneedle516,6690 00For
TIAA512,4210 00For
Royce398,0770 00For
Segall Bryant & Hamill Trust379,3580 00For
Equitable356,7260 00For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

9. Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

75% Majority: yes · of votes cast

FOR 75%WITHHELD 25%
FOR: 83,003,873WITHHELD: 27,070,660

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Lynn A. Tetrault”): 83,003,873 for, 27,070,660 withheld, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,434,786 outstanding shares: 65% for, 21% withheld (86% of the company cast a for/withheld vote).

The 91 asset managers below cast 100% of the shares they voted on this item FOR (53,329,063 for, 0 against).

FOR 81%ABSTAIN 19%
FOR: 53,329,063 (80.7%)ABSTAIN: 12,673,459 (19.2%)NOT VOTED: 98,642 (0.1%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Lynn A. Tetrault” at NEOGENOMICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,967,2100 00For
BlackRock12,124,7710 00For
T. Rowe Price4,733,3860 464,7980For
JANUS INVESTMENT FUND3,693,9820 926,8190For
Brown Advisory Funds3,130,9870 00For
Fidelity2,778,1350 00For
Delaware/Macquarie00 2,495,0200Abstain
American Century00 2,181,0420Abstain
State Street1,890,6240 3,0670For
Principal1,560,2290 145,5480For
Goldman Sachs1,348,9700 00For
FRANKLIN STRATEGIC SERIES1,270,4000 00For
GLENMEDE FUND INC00 1,057,0490Abstain
Charles Schwab1,011,5570 00For
FINANCIAL INVESTORS TRUST817,4380 00For
OBERWEIS FUNDS00 732,2000Abstain
Waddell & Reed00 710,7690Abstain
Putnam667,0820 00For
ALGER FUNDS00 643,9420Abstain
Prudential/PGIM493,3470 57,3030For
Columbia Threadneedle516,6690 00For
TIAA00 512,4210Abstain
Royce398,0770 00For
Segall Bryant & Hamill Trust00 379,3580Abstain
Equitable199,8860 156,8400For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

10. Election of the directors named in the proxy statement as set forth below: Michael A. Kelly

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

77% Majority: yes · of votes cast

FOR 77%WITHHELD 23%
FOR: 84,662,179WITHHELD: 25,412,354

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Michael A. Kelly”): 84,662,179 for, 25,412,354 withheld, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,434,786 outstanding shares: 66% for, 20% withheld (86% of the company cast a for/withheld vote).

The 91 asset managers below cast 100% of the shares they voted on this item FOR (53,329,063 for, 0 against).

FOR 81%ABSTAIN 19%
FOR: 53,329,063 (80.7%)ABSTAIN: 12,673,459 (19.2%)NOT VOTED: 98,642 (0.1%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Michael A. Kelly” at NEOGENOMICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,967,2100 00For
BlackRock12,124,7710 00For
T. Rowe Price4,733,3860 464,7980For
JANUS INVESTMENT FUND3,693,9820 926,8190For
Brown Advisory Funds3,130,9870 00For
Fidelity2,778,1350 00For
Delaware/Macquarie00 2,495,0200Abstain
American Century00 2,181,0420Abstain
State Street1,890,6240 3,0670For
Principal1,560,2290 145,5480For
Goldman Sachs1,348,9700 00For
FRANKLIN STRATEGIC SERIES1,270,4000 00For
GLENMEDE FUND INC00 1,057,0490Abstain
Charles Schwab1,011,5570 00For
FINANCIAL INVESTORS TRUST817,4380 00For
OBERWEIS FUNDS00 732,2000Abstain
Waddell & Reed00 710,7690Abstain
Putnam667,0820 00For
ALGER FUNDS00 643,9420Abstain
Prudential/PGIM493,3470 57,3030For
Columbia Threadneedle516,6690 00For
TIAA00 512,4210Abstain
Royce398,0770 00For
Segall Bryant & Hamill Trust00 379,3580Abstain
Equitable199,8860 156,8400For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

11. Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 107,073,992WITHHELD: 3,000,541

NEOGENOMICS INC.’s own tally for this item (“Elect Director: Stephen M. Kanovsky”): 107,073,992 for, 3,000,541 withheld, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,434,786 outstanding shares: 84% for, 2% withheld (86% of the company cast a for/withheld vote).

The 91 asset managers below cast 100% of the shares they voted on this item FOR (65,217,862 for, 0 against).

FOR 99%
FOR: 65,217,862 (98.7%)ABSTAIN: 784,660 (1.2%)NOT VOTED: 98,642 (0.1%)
Largest asset managers voting on “Election of the directors named in the proxy statement as set forth below: Stephen M. Kanovsky” at NEOGENOMICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,967,2100 00For
BlackRock12,124,7710 00For
T. Rowe Price5,198,1840 00For
JANUS INVESTMENT FUND4,620,8010 00For
Brown Advisory Funds3,130,9870 00For
Fidelity2,778,1350 00For
Delaware/Macquarie2,495,0200 00For
American Century2,181,0420 00For
State Street1,892,9160 7750For
Principal1,705,7770 00For
Goldman Sachs1,348,9700 00For
FRANKLIN STRATEGIC SERIES1,270,4000 00For
GLENMEDE FUND INC1,057,0490 00For
Charles Schwab1,011,5570 00For
FINANCIAL INVESTORS TRUST817,4380 00For
OBERWEIS FUNDS732,2000 00For
Waddell & Reed710,7690 00For
Putnam667,0820 00For
ALGER FUNDS00 643,9420Abstain
Prudential/PGIM550,6500 00For
Columbia Threadneedle516,6690 00For
TIAA512,4210 00For
Royce398,0770 00For
Segall Bryant & Hamill Trust379,3580 00For
Equitable356,7260 00For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

12. Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 117,159,931AGAINST: 384,034

NEOGENOMICS INC.’s own tally for this item (“Proposal 4: The ratification of the appointment of Deloitte & Touche LLP as the independent registered public accountant. The stockholders approved the proposal by the following vote:”): 117,159,931 for, 384,034 against, per its Form 8-K filed 2024-05-24 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 127,434,786 outstanding shares: 92% for, 0.4% against (92% of the company cast a for/against vote).

The 91 asset managers below cast 99.9% of the shares they voted on this item FOR (65,931,799 for, 60,566 against).

FOR 99.7%
FOR: 65,931,799 (99.7%)AGAINST: 60,566 (0.1%)ABSTAIN: 10,157 (0.0%)NOT VOTED: 98,642 (0.1%)
Largest asset managers voting on “Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accoun” at NEOGENOMICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard13,967,2100 00For
BlackRock12,124,7710 00For
T. Rowe Price5,198,1840 00For
JANUS INVESTMENT FUND4,620,8010 00For
Brown Advisory Funds3,130,9870 00For
Fidelity2,778,1350 00For
Delaware/Macquarie2,495,0200 00For
American Century2,181,0420 00For
State Street1,893,6910 00For
Principal1,705,7770 00For
Goldman Sachs1,348,9700 00For
FRANKLIN STRATEGIC SERIES1,270,4000 00For
GLENMEDE FUND INC1,057,0490 00For
Charles Schwab1,011,5570 00For
FINANCIAL INVESTORS TRUST817,4380 00For
OBERWEIS FUNDS732,2000 00For
Waddell & Reed710,7690 00For
Putnam667,0820 00For
ALGER FUNDS643,9420 00For
Prudential/PGIM550,6500 00For
Columbia Threadneedle516,6690 00For
TIAA512,4210 00For
Royce398,0770 00For
Segall Bryant & Hamill Trust379,3580 00For
Equitable356,7260 00For

Showing the 25 largest of 91 asset managers. See all 91 in the interactive database.

Largest NEOGENOMICS INC. shareholders voting in 2023-2024

Ranked by the number of NEOGENOMICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 127,434,786 shares outstanding at the time of that meeting.

Top NEOGENOMICS INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1New York Life 13.57%
2BlackRock 12.12%
3Vanguard 11.14%
4T. Rowe Price 9.91%
5BROWN ADVISORY INC 6.43%
6State Street 4.95%
7Janus Henderson 4.45%
8JANUS INVESTMENT FUND 3.63%
9American Century 3.61%
10MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST 2.95%

Reported NEOGENOMICS INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

NEOGENOMICS INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 15.14% 13F
Vanguard Group 10.91% 13F
Brown Advisory Incorporated 7.48% DEF14A
T. Rowe Price Investment Management Inc. 5.01% DEF14A
State Street 3.84% 13F
Dimensional Fund Advisors 2.44% 13F
Geode Capital 2.28% 13F
Morgan Stanley 2.09% 13F
Point72 1.72% 13F
Franklin Templeton 1.67% 13F

Percentages above are of 127,434,786 shares outstanding, as reported by NEOGENOMICS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from NEOGENOMICS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At NEOGENOMICS INC.'s shareholder meeting held 2024-05-23, in the 2023-2024 proxy season, 312 asset managers reported how they voted on 12 ballot items in their SEC Form N-PX filings, covering 3,787 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory basis, of the Compensation Paid to the Company's Named Executive… — FOR was 70% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: NEOGENOMICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-05-24.

NEOGENOMICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.